Furthermore, correlation analysis demonstrated that high USP22 expression was correlated with clinical stage (p= 0.002 for the training set and p= 0.026 for the test set) and tumor grade (p= 0.004 for the training set and p = 0.001 for the test set). This evidence concerns the gene USP22 and neoplasm.